• White Twitter Icon
  • White LinkedIn Icon

©2019 by Solas BioVentures

RECENT

OCT 23, 2019

Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors

AUG 7, 2019

Renovia Study Results Published in Neurourology and UrodynamicsShow Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence

MAY 16, 2019

Transomic CRISPR Library to be Implemented at the Victorian Centre for Functional Genomics

APR 22, 2019

AEGEA Medical Completes Enrollment in PACE MX, the Third Study Assessing Long-Term Access to the Uterine Cavity after Endometrial Ablation with Water Vapor

APR 9, 2019

David Adair, Managing Director of Solas BioVentures, Joins Panel on De-risking Medtech Innovation at SEMDA 2019 Conference 

APR 5, 2019

Transomic CRISPR library to be implemented at UCLA

Apr 3, 2019

Breakthrough Innovation: The HAART Aortic Annuloplasty Device Cleared by the FDA (BioStable S&E)

APR 2, 2019

Eight Teams in CO.LAB's Inaugural “HealthTech Accelerator” Unveiled at Chattanooga Event (PreTel)

MAR 28, 2019

Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards

MAR 19, 2019

St. Louis Medical Device Startup Elira Inc. Raises Over $900K in Debt Offering

MAR 18, 2019

Is Chattanooga the Sweet Spot for Early Stage Medtech Innovators? (SEMDA)

MAR 12, 2019

Duke Engineering Program Adds Entrepreneur-in-Residence (Baebies)

FEB 22, 2019

Procedure in Indiana Provides Important New Option for Heart Valve Repair (BioStable S&E)

FEB 13, 2019

Transomic CRISPR library to be implemented at McGill University 

Solas - Horizontal - Logo - Full Color.p